| Status | Study |
| Not yet recruiting |
Study Name: A Safety, Pharmacokinetic, Single Ascending Dose Study of Tesevatinib in Pediatric Subjects With Autosomal Recessive Polycystic Kidney Disease (ARPKD) Condition: Polycystic Kidney, Autosomal Recessive Date: 2017-03-06 Interventions: Drug: Tesevatinib One dose of the study drug in liquid form |
| Recruiting |
Study Name: UAB HRFD Core Center: Core A: The Hepato/Renal Fibrocystic Diseases Translational Resource Condition: Hepato/Renal Fibrocystic Disease Autosomal Recessive Polycystic Kidney Date: 2011-07-22 |
| Completed |
Study Name: UAB Recessive PKD Research and Translational Core Center Condition: Autosomal Recessive Polycystic Kidney Disease Date: 2007-12-13 |
| Active, not recruiting |
Study Name: Clinical and Molecular Investigations Into Ciliopathies Condition: Autosomal Recessive Polycystic Kidney Disease Congenital Hepati Date: 2003-09-10 |